title: Effect of protein kinase C delta (PKC-δ) inhibition on the transcriptome of normal and systemic sclerosis human dermal fibroblasts in vitro.
abstract: Previous studies demonstrated that protein kinase C- δ (PKC-δ) inhibition with the selective inhibitor, rottlerin, resulted in potent downregulation of type I collagen expression and production in normal human dermal fibroblasts and abrogated the exaggerated type I collagen production and expression in fibroblasts cultured from affected skin from patients with the fibrosing disorder systemic sclerosis (SSc). To elucidate the mechanisms involved in the ability of PKC-δ to regulate collagen production in fibroblasts, we examined the effects of PKC-δ inhibition on the transcriptome of normal and SSc human dermal fibroblasts. Normal and SSc human dermal fibroblasts were incubated with rottlerin (5 µM), and their gene expression was analyzed by microarrays. Pathway analysis and gene ontology analysis of differentially expressed genes in each comparison were performed. Identification of significantly overrepresented transcriptional regulatory elements (TREs) was performed using the Promoter Analysis and Interaction Network Toolset (PAINT) program. PKC-δ activity was also inhibited using RNA interference (siRNA) and by treating fibroblasts with a specific PKC-δ inhibitory cell permeable peptide. Differential gene expression of 20 genes was confirmed using real time PCR. PKC-δ inhibition caused a profound change in the transcriptome of normal and SSc human dermal fibroblasts in vitro. Pathway and gene ontology analysis identified multiple cellular and organismal pathways affected by PKC-δ inhibition. Furthermore, both pathway and PAINT analyses indicated that the transcription factor NFκB played an important role in the transcriptome changes induced by PKC-δ inhibition. Multiple genes involved in the degradation of the extracellular matrix components were significantly reduced in SSc fibroblasts and their expression was increased by PKC-δ inhibition. These results indicate that isoform-specific inhibition of PKC-δ profibrotic effects may represent a novel therapeutic approach for SSc and other fibrotic diseases.
authors.affiliation: Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Wermuth
authors.forename: Sankar
authors.initials: S
authors.lastname: Addya
authors.forename: Sergio A
authors.initials: SA
authors.lastname: Jimenez
mesh_terms: D000098:Acetophenones / Q000494:pharmacology; D001578:Benzopyrans / Q000494:pharmacology; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D051745:Protein Kinase C-delta / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012595:Scleroderma, Systemic / Q000378:metabolism / Q000473:pathology*; D012867:Skin / Q000166:cytology* / Q000378:metabolism / Q000473:pathology*
chemical_list: D000098:Acetophenones; D001578:Benzopyrans; D004791:Enzyme Inhibitors; C085746:rottlerin; D051745:Protein Kinase C-delta
references.citation: Mucosal Immunol. 2009 Jan;2(1):33-42
references.pmid: 19079332
references.citation: J Clin Invest. 2001 Nov;108(9):1395-403
references.pmid: 11696585
references.citation: Biochem Biophys Res Commun. 1994 Feb 28;199(1):93-8
references.pmid: 8123051
references.citation: J Clin Invest. 2002 Nov;110(9):1349-58
references.pmid: 12417574
references.citation: J Biol Chem. 2004 Oct 8;279(41):42703-8
references.pmid: 15299019
references.citation: Trends Pharmacol Sci. 2004 Oct;25(10):528-35
references.pmid: 15380937
references.citation: J Biol Chem. 2003 Dec 19;278(51):51091-9
references.pmid: 14527959
references.citation: Clin Exp Rheumatol. 2004 Jan-Feb;22(3 Suppl 33):S66-72
references.pmid: 15344601
references.citation: Mol Ther. 2000 Oct;2(4):339-47
references.pmid: 11020349
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11114-9
references.pmid: 11553773
references.citation: Fibrogenesis Tissue Repair. 2011 Jul 01;4(1):15
references.pmid: 21722364
references.citation: Biochem J. 2004 Dec 15;384(Pt 3):449-59
references.pmid: 15491280
references.citation: J Biol Chem. 2000 May 19;275(20):15336-42
references.pmid: 10809768
references.citation: J Clin Invest. 2004 Aug;114(3):438-46
references.pmid: 15286810
references.citation: Arthritis Rheum. 2006 Jun;54(6):1961-73
references.pmid: 16736506
references.citation: J Rheumatol. 1988 Feb;15(2):202-5
references.pmid: 3361530
references.citation: Methods Mol Biol. 2007;408:49-68
references.pmid: 18314577
references.citation: FASEB J. 2004 Apr;18(6):627-36
references.pmid: 15054085
references.citation: J Immunol. 2003 Jun 1;170(11):5681-9
references.pmid: 12759450
references.citation: Methods Mol Biol. 2003;233:3-7
references.pmid: 12840493
references.citation: Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):780-6
references.pmid: 16469949
references.citation: J Immunol. 2007 Sep 1;179(5):3297-304
references.pmid: 17709546
references.citation: FEBS Lett. 1987 Nov 2;223(2):212-6
references.pmid: 3666147
references.citation: OMICS. 2003 Fall;7(3):235-52
references.pmid: 14583114
references.citation: Exp Cell Res. 2004 Jul 1;297(1):165-85
references.pmid: 15194434
references.citation: Nat Genet. 1997 Jun;16(2):174-8
references.pmid: 9171829
references.citation: Am J Physiol Renal Physiol. 2003 Sep;285(3):F413-22
references.pmid: 12759229
references.citation: Genes Dev. 1992 Mar;6(3):439-53
references.pmid: 1547942
references.citation: Nat Immunol. 2004 Aug;5(8):785-90
references.pmid: 15282562
references.citation: Trends Pharmacol Sci. 2007 Sep;28(9):453-8
references.pmid: 17692392
references.citation: PLoS One. 2008 Jul 16;3(7):e2696
references.pmid: 18648520
references.citation: Arthritis Rheum. 2003 Mar;48(3):798-806
references.pmid: 12632435
references.citation: Nature. 1987 Jan 8-14;325(7000):107-8
references.pmid: 3808066
references.citation: J Leukoc Biol. 2009 Nov;86(5):1111-8
references.pmid: 19581373
references.citation: J Biol Chem. 1997 Jan 17;272(3):1842-8
references.pmid: 8999870
references.citation: Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11514-9
references.pmid: 9326641
references.citation: Arthritis Rheum. 2005 Mar;52(3):865-76
references.pmid: 15751056
references.citation: J Biol Chem. 1994 Nov 18;269(46):29308-13
references.pmid: 7961901
references.citation: J Biol Chem. 1983 Oct 25;258(20):12238-42
references.pmid: 6313646
references.citation: Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G342-50
references.pmid: 15831713
references.citation: FASEB J. 1998 Jan;12(1):35-42
references.pmid: 9438408
references.citation: J Rheumatol. 2009 May;36(5):976-83
references.pmid: 19273457
references.citation: Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E395-402
references.pmid: 19934406
references.citation: Gastroenterology. 2005 Dec;129(6):2064-75
references.pmid: 16344072
references.citation: Am J Respir Cell Mol Biol. 2008 Oct;39(4):482-9
references.pmid: 18421013
references.citation: Clin Exp Rheumatol. 2008 Sep-Oct;26(5):866-74
references.pmid: 19032821
references.citation: Mol Cell. 2002 Nov;10(5):995-1005
references.pmid: 12453409
references.citation: Bioessays. 2000 Mar;22(3):245-54
references.pmid: 10684584
references.citation: J Biol Chem. 2008 May 16;283(20):14063-71
references.pmid: 18296708
references.citation: Biochem J. 1998 Jul 15;333 ( Pt 2):359-66
references.pmid: 9657976
references.citation: Biochem Biophys Res Commun. 1987 Sep 30;147(3):1282-8
references.pmid: 3478047
references.citation: Int Rev Connect Tissue Res. 1981;9:151-90
references.pmid: 6175596